GeoVax Labs Files 2024 10-K, Details March 2025 Warrant Offering
Ticker: GOVX · Form: 10-K · Filed: Mar 27, 2025 · CIK: 832489
Sentiment: neutral
Topics: 10-K, financing, subsequent-event
TL;DR
GeoVax 2024 10-K is in. Big warrant deal happened March 24, 2025.
AI Summary
GeoVax Labs, Inc. filed its 10-K for the fiscal year ending December 31, 2024. The company, based in Smyrna, GA, reported on its operations in the pharmaceutical preparations sector. A significant subsequent event noted was an offering that occurred on March 24, 2025, involving common warrants.
Why It Matters
This filing provides a comprehensive overview of GeoVax Labs' financial health and operational status for 2024, including recent financing activities that could impact future growth.
Risk Assessment
Risk Level: medium — The company's financial performance and future prospects are subject to the inherent risks of the pharmaceutical industry and the success of its product development and financing activities.
Key Numbers
- 2024-12-31 — Fiscal Year End (Reporting period for the 10-K)
- 2025-03-24 — Subsequent Event Date (Date of the March 2025 offering)
Key Players & Entities
- GeoVax Labs, Inc. (company) — Filer of the 10-K
- 2024-12-31 (date) — Fiscal year end
- Smyrna, GA (location) — Company headquarters
- March 24, 2025 (date) — Date of subsequent event (offering)
- common warrants (security) — Instrument involved in the March 2025 offering
FAQ
What was the total revenue for GeoVax Labs in fiscal year 2024?
The provided text does not contain specific revenue figures for fiscal year 2024.
What is the primary business of GeoVax Labs, Inc.?
GeoVax Labs, Inc. operates in the Pharmaceutical Preparations sector, SIC code 2834.
What specific event occurred on March 24, 2025, as a subsequent event?
On March 24, 2025, GeoVax Labs, Inc. was involved in an offering that included common warrants.
Where is GeoVax Labs, Inc. headquartered?
GeoVax Labs, Inc. is headquartered at 1900 Lake Park Drive, Suite 380, Smyrna, GA 30080.
What is the SEC file number for GeoVax Labs, Inc.'s 10-K filing?
The SEC file number for this filing is 001-39563.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on March 27, 2025 regarding GeoVax Labs, Inc. (GOVX).